BIIB

Biogen
D

BIIB

Arincen57/100B

Biogen cash on hand 1985–2026

Biogen had 1.30B USD in cash and short-term investments on 30 September 2026, down 67.1% on a year before. At the end of fiscal year 2025 it had 3.82B USD.

Last updated 9 Nov 2026 · Next report 5 Feb 2027

Cash on hand

Growth

Fiscal yearPeriod endingCash on handGrowthTotal debtNet cash
Latest quarter30 Sept 20261.30B-67.08%7.80B-6.50B
FY202531 Dec 20253.82B+60.66%6.95B-3.13B
FY202431 Dec 20242.38B+126.21%6.63B-4.26B
FY202331 Dec 20231.05B-78.54%7.34B-6.29B
FY202231 Dec 20224.89B+28.67%6.61B-1.72B
FY202131 Dec 20213.80B+45.68%7.60B-3.80B
FY202031 Dec 20202.61B-41.69%7.83B-5.22B
FY201931 Dec 20194.48B+26.51%6.37B-1.89B
FY201831 Dec 20183.54B-4.09%5.94B-2.40B
FY201731 Dec 20173.69B-24.64%5.94B-2.25B
FY201631 Dec 20164.90B+42.78%6.52B-1.62B
FY201531 Dec 20153.43B+85.79%6.53B-3.10B
FY201431 Dec 20141.85B+50.92%585.20M1.26B
FY201331 Dec 20131.22B-28.32%595.93M626.80M
FY201231 Dec 20121.71B+0.89%1.14B564.94M
FY201131 Dec 20111.69B+39.98%1.06B626.56M
FY201031 Dec 20101.21B-4.43%1.20B4.21M
FY200931 Dec 20091.26B-7.85%1.10B163.76M
FY200831 Dec 20081.37B+15.88%1.11B258.32M
FY200731 Dec 20071.18B+31.11%1.56B-379.48M
FY200631 Dec 2006902.69M+6.10%96.69M806.00M
FY200531 Dec 2005850.75M-19.58%43.44M807.31M
FY200431 Dec 20041.06B+26.55%850.31M207.63M
FY200331 Dec 2003835.96M-3.59%887.27M-51.31M
FY200231 Dec 2002867.11M+8.65%42.30M824.81M
FY200131 Dec 2001798.11M+16.95%82.16M715.95M
FY200031 Dec 2000682.41M+4.26%109.32M573.09M
FY199931 Dec 1999654.54M+26.62%113.06M541.48M
FY199831 Dec 1998516.91M+17.46%80.33M436.59M
FY199731 Dec 1997440.09M+36.94%91.55M348.54M
FY199631 Dec 1996321.38M+4.36%66.27M255.11M
FY199531 Dec 1995307.95M+14.99%34.49M273.46M
FY199431 Dec 1994267.80M+259.47%0.00267.80M
FY199331 Dec 199374.50M-13.27%0.0074.50M
FY199231 Dec 199285.90M+51.77%0.0085.90M
FY199131 Dec 199156.60M+349.21%0.0056.60M
FY199031 Dec 199012.60M-62.05%0.0012.60M
FY198931 Dec 198933.20M-38.86%0.0033.20M
FY198831 Dec 198854.30M-0.18%4.80M49.50M
FY198731 Dec 198754.40M-22.84%5.20M49.20M
FY198631 Dec 198670.50M+31.78%4.40M66.10M
FY198531 Dec 198553.50M—3.60M49.90M

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet

Common questions about Biogen's cash

Source: Financial Modeling Prep